
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-a68b4900.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-0a3f24ce.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Brief Report: Resolution of Neuropsychiatric Adverse Events After Switching to a Doravirine-Based Regimen in the Open-Label Extensions of the DRIVE-AHEAD and DRIVE-FORWARD Trials - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="68F7E11680955CB300E1160005728A1A.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="lwwopen">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11970612/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Journal of Acquired Immune Deficiency Syndromes (1999)">
<meta name="citation_title" content="Brief Report: Resolution of Neuropsychiatric Adverse Events After Switching to a Doravirine-Based Regimen in the Open-Label Extensions of the DRIVE-AHEAD and DRIVE-FORWARD Trials">
<meta name="citation_author" content="Graeme Moyle">
<meta name="citation_author_institution" content="Chelsea &amp; Westminster Hospital, London, United Kingdom;">
<meta name="citation_author" content="Fanxia Meng">
<meta name="citation_author_institution" content="Merck &amp; Co., Inc., Rahway, NJ; and">
<meta name="citation_author" content="Hong Wan">
<meta name="citation_author_institution" content="Merck &amp; Co., Inc., Rahway, NJ; and">
<meta name="citation_author" content="Peter Sklar">
<meta name="citation_author_institution" content="Merck &amp; Co., Inc., Rahway, NJ; and">
<meta name="citation_author" content="Rebeca M Plank">
<meta name="citation_author_institution" content="Merck &amp; Co., Inc., Rahway, NJ; and">
<meta name="citation_author" content="Rima Lahoulou">
<meta name="citation_author_institution" content="MSD France, Puteaux, France.">
<meta name="citation_publication_date" content="2025 Jan 3">
<meta name="citation_volume" content="99">
<meta name="citation_issue" content="1">
<meta name="citation_firstpage" content="81">
<meta name="citation_doi" content="10.1097/QAI.0000000000003599">
<meta name="citation_pmid" content="39748155">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC11970612/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC11970612/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC11970612/pdf/qai-99-81.pdf">
<meta name="description" content="Supplemental Digital Content is Available in the Text. Key Words: doravirine, non-nucleoside reverse transcriptase inhibitor, HIV-1, treatment experienced, switch, safety, neuropsychiatric adverse events">
<meta name="og:title" content="Brief Report: Resolution of Neuropsychiatric Adverse Events After Switching to a Doravirine-Based Regimen in the Open-Label Extensions of the DRIVE-AHEAD and DRIVE-FORWARD Trials">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Supplemental Digital Content is Available in the Text. Key Words: doravirine, non-nucleoside reverse transcriptase inhibitor, HIV-1, treatment experienced, switch, safety, neuropsychiatric adverse events">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC11970612/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-testid="header" data-header >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            
                <a class="ncbi-header__logo-container" href="https://www.ncbi.nlm.nih.gov/">
                    <img alt="
                                  NCBI home page
                              "
                         class="ncbi-header__logo-image"
                         src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg" />
                </a>
            

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-testid="searchPanel"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      aria-describedby="search-field-desktop-navigation-help-text"
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only"
                           data-testid="label"
                           for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           data-testid="textInput"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    data-testid="button"
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  role="search">
                <label class="usa-sr-only" for="search-field">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="search" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        <a class="usa-link" href="https://www.ncbi.nlm.nih.gov/pmc/advanced/" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="11970612">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1097/QAI.0000000000003599"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/qai-99-81.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC11970612%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/11970612/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/11970612/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC11970612/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-lwwopen.png" alt="Lippincott Open Access logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Lippincott Open Access" title="Link to Lippincott Open Access" shape="default" href="https://doi.org/10.1097/QAI.0000000000003599" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">J Acquir Immune Defic Syndr</button></div>. 2025 Jan 3;99(1):81–86. doi: <a href="https://doi.org/10.1097/QAI.0000000000003599" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1097/QAI.0000000000003599</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22J%20Acquir%20Immune%20Defic%20Syndr%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22J%20Acquir%20Immune%20Defic%20Syndr%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22J%20Acquir%20Immune%20Defic%20Syndr%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22J%20Acquir%20Immune%20Defic%20Syndr%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Brief Report: Resolution of Neuropsychiatric Adverse Events After Switching to a Doravirine-Based Regimen in the Open-Label Extensions of the DRIVE-AHEAD and DRIVE-FORWARD Trials</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Moyle%20G%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Graeme Moyle</span></a><div hidden="hidden" id="id1">
<h3>
<span class="name western">Graeme Moyle</span>, <span class="degrees">MBBS, MD</span>
</h3>
<div class="p">
<sup>a</sup>Chelsea &amp; Westminster Hospital, London, United Kingdom;</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Moyle%20G%22%5BAuthor%5D" class="usa-link"><span class="name western">Graeme Moyle</span></a>
</div>
</div>
<sup>a</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Meng%20F%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Fanxia Meng</span></a><div hidden="hidden" id="id2">
<h3>
<span class="name western">Fanxia Meng</span>, <span class="degrees">MPH</span>
</h3>
<div class="p">
<sup>b</sup>Merck &amp; Co., Inc., Rahway, NJ; and</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Meng%20F%22%5BAuthor%5D" class="usa-link"><span class="name western">Fanxia Meng</span></a>
</div>
</div>
<sup>b</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wan%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Hong Wan</span></a><div hidden="hidden" id="id3">
<h3>
<span class="name western">Hong Wan</span>, <span class="degrees">PhD</span>
</h3>
<div class="p">
<sup>b</sup>Merck &amp; Co., Inc., Rahway, NJ; and</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wan%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Hong Wan</span></a>
</div>
</div>
<sup>b</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sklar%20P%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Peter Sklar</span></a><div hidden="hidden" id="id4">
<h3>
<span class="name western">Peter Sklar</span>, <span class="degrees">MD, MPH</span>
</h3>
<div class="p">
<sup>b</sup>Merck &amp; Co., Inc., Rahway, NJ; and</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sklar%20P%22%5BAuthor%5D" class="usa-link"><span class="name western">Peter Sklar</span></a>
</div>
</div>
<sup>b</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Plank%20RM%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Rebeca M Plank</span></a><div hidden="hidden" id="id5">
<h3>
<span class="name western">Rebeca M Plank</span>, <span class="degrees">MD, MPH</span>
</h3>
<div class="p">
<sup>b</sup>Merck &amp; Co., Inc., Rahway, NJ; and</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Plank%20RM%22%5BAuthor%5D" class="usa-link"><span class="name western">Rebeca M Plank</span></a>
</div>
</div>
<sup>b</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lahoulou%20R%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Rima Lahoulou</span></a><div hidden="hidden" id="id6">
<h3>
<span class="name western">Rima Lahoulou</span>, <span class="degrees">MD</span>
</h3>
<div class="p">
<sup>c</sup>MSD France, Puteaux, France.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lahoulou%20R%22%5BAuthor%5D" class="usa-link"><span class="name western">Rima Lahoulou</span></a>
</div>
</div>
<sup>c,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff1">
<sup>a</sup>Chelsea &amp; Westminster Hospital, London, United Kingdom;</div>
<div id="aff2">
<sup>b</sup>Merck &amp; Co., Inc., Rahway, NJ; and</div>
<div id="aff3">
<sup>c</sup>MSD France, Puteaux, France.</div>
<div class="author-notes p">
<div class="fn" id="corresp1">
<sup>✉</sup><p class="display-inline">Correspondence to: Rima Lahoulou, MD, 10-12 Cours Michelet, Puteaux, France (e-mail: <span>rima.lahoulou@msd.com</span>).</p>
</div>
<div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2024 Sep 4; Accepted 2024 Dec 12; Issue date 2025 May 1.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>Copyright © 2025 The Author(s). Published by Wolters Kluwer Health, Inc.</div>
<p>This is an open access article distributed under the terms of the <a href="https://creativecommons.org/licenses/by-nc-nd/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND)</a>, where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC11970612  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/39748155/" class="usa-link">39748155</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><hr class="headless">
<p>Supplemental Digital Content is Available in the Text.</p>
<section id="kwd-group1" class="kwd-group"><p><strong>Key Words:</strong> doravirine, non-nucleoside reverse transcriptase inhibitor, HIV-1, treatment experienced, switch, safety, neuropsychiatric adverse events</p></section></section><section class="abstract" id="abstract2"><h2>Abstract</h2>
<section id="sec1"><h3 class="pmc_sec_title">Background:</h3>
<p>Neuropsychiatric adverse events (NPAEs) are associated with several antiretrovirals. Doravirine (DOR), a non-nucleoside reverse transcriptase inhibitor indicated for HIV-1 treatment, does not interact significantly with known neurotransmitter receptors in vitro. First-line therapy with DOR-based regimens resulted in significantly fewer NPAEs than efavirenz/emtricitabine/tenofovir disoproxil fumarate (EFV/FTC/TDF) and similar rates to those of ritonavir-boosted darunavir (DRV/r) with 2 nucleos(t)ide reverse transcriptase inhibitors (NRTIs) through week 96 of the phase 3 DRIVE-AHEAD and DRIVE-FORWARD studies, respectively.</p></section><section id="sec2"><h3 class="pmc_sec_title">Methods:</h3>
<p>In the DRIVE-AHEAD (<a href="https://clinicaltrials.gov/ct2/show/NCT02403674" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT02403674</a>) and DRIVE-FORWARD studies (<a href="https://clinicaltrials.gov/ct2/show/NCT02275780" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT02275780</a>), treatment-naive adults randomly received DOR/lamivudine/TDF or EFV/FTC/TDF and DOR + 2 NRTIs or DRV/r + 2 NRTIs, respectively, for a 96-week double-blind phase; afterward, participants could continue or switch to a DOR-based regimen for a 96-week open-label extension.</p></section><section id="sec3"><h3 class="pmc_sec_title">Results:</h3>
<p>Overall, 269 and 233 participants in the DRIVE-AHEAD and DRIVE-FORWARD studies, respectively, switched to a DOR-based regimen. At week 96, 26 and 15 participants randomized to EFV/FTC/TDF and DRV/r + 2 NRTIs, respectively, had ongoing NPAEs, resolving by week 192 in 73% (19/26) and 40% (6/15) of participants switching to a DOR-based regimen. New-onset NPAEs were reported by 9% (25/269) and 8% (18/233) of participants; by week 192, new-onset NPAEs were resolved and/or resolving in 60% (15/25) and 61% (11/18) of participants.</p></section><section id="sec4"><h3 class="pmc_sec_title">Conclusions:</h3>
<p>In both trial extensions, NPAEs persisted in 3%–4% of participants 96 weeks after switching to a DOR-based regimen, possibly representing the background rate for these events. This suggests that DOR-based therapy may be a good option for adults with baseline neuropsychiatric symptoms or those experiencing NPAEs with other antiretrovirals.</p></section></section><section id="s1"><h2 class="pmc_sec_title">INTRODUCTION</h2>
<p>Although antiretroviral therapy (ART) has led to tremendous reductions in HIV-1–associated mortality and morbidity, including neurocognitive disorders,<sup><a href="#R1" class="usa-link" aria-describedby="R1">1</a>–<a href="#R3" class="usa-link" aria-describedby="R3">3</a></sup> some regimens are associated with nervous system and psychiatric adverse effects.<sup><a href="#R4" class="usa-link" aria-describedby="R4">4</a></sup> ART-related neuropsychiatric adverse events (NPAEs) include confusion, anxiety, depression, somnolence, insomnia, abnormal dreams, dizziness, agitation, hallucinations, and other psychotic disturbances that have been associated with ART initiation or switch.<sup><a href="#R5" class="usa-link" aria-describedby="R5">5</a></sup></p>
<p>The incidence and severity of NPAEs are highly variable, with differences between not only antiretroviral classes, but also individual drugs within each class.<sup><a href="#R4" class="usa-link" aria-describedby="R4">4</a>–<a href="#R6" class="usa-link" aria-describedby="R6">6</a></sup> Furthermore, discontinuation rates of dolutegravir and other integrase strand transfer inhibitors (InSTIs) because of NPAEs have been higher in clinical practice than in randomized controlled trials.<sup><a href="#R7" class="usa-link" aria-describedby="R7">7</a>,<a href="#R8" class="usa-link" aria-describedby="R8">8</a></sup> The most reported NPAEs with InSTIs have been insomnia, abnormal dreams, anxiety, headache, and depression, occurring in 4.0%–35.0% of participants.<sup><a href="#R9" class="usa-link" aria-describedby="R9">9</a></sup> In a retrospective study, more participants discontinued dolutegravir (5.6%) within 12 months because of NPAEs than discontinued elvitegravir (0.7%) or raltegravir (1.9%).<sup><a href="#R7" class="usa-link" aria-describedby="R7">7</a></sup> In another retrospective analysis, after a median follow-up of 6.2 months, 3.3% of participants discontinued the fixed-dose combination of bictegravir/emtricitabine (FTC)/tenofovir alafenamide because of NPAEs.<sup><a href="#R8" class="usa-link" aria-describedby="R8">8</a></sup></p>
<p>For the non-nucleoside reverse transcriptase inhibitor efavirenz (EFV), NPAEs were the most common adverse events, with more than 50.0% of participants reporting such adverse events in most clinical trials.<sup><a href="#R10" class="usa-link" aria-describedby="R10">10</a>–<a href="#R12" class="usa-link" aria-describedby="R12">12</a></sup> Accordingly, experiencing NPAEs has been one of the main reasons for discontinuation of EFV.<sup><a href="#R13" class="usa-link" aria-describedby="R13">13</a></sup> The most frequently reported NPAEs with EFV are abnormal dreams, sleep disturbances, insomnia, dizziness, anxiety, and depression.<sup><a href="#R10" class="usa-link" aria-describedby="R10">10</a>–<a href="#R13" class="usa-link" aria-describedby="R13">13</a></sup> Preclinical studies suggest that EFV-induced neurotoxicity may be mediated through interactions with receptors (eg, serotonin 5-HT) and transporters (eg, serotonin, dopamine) known to be targets for drugs of abuse.<sup><a href="#R5" class="usa-link" aria-describedby="R5">5</a>,<a href="#R14" class="usa-link" aria-describedby="R14">14</a>,<a href="#R15" class="usa-link" aria-describedby="R15">15</a></sup> Together, these data highlight the need for alternative treatment options for those experiencing NPAEs with current first-line antiretroviral regimens.</p>
<p>Doravirine (DOR) is a non-nucleoside reverse transcriptase inhibitor indicated for the treatment of HIV-1 in adults and adolescents.<sup><a href="#R16" class="usa-link" aria-describedby="R16">16</a>,<a href="#R17" class="usa-link" aria-describedby="R17">17</a></sup> Doravirine was designed to address known disadvantages of other approved non-nucleoside reverse transcriptase inhibitors, minimize neuropsychiatric and lipid effects, reduce resistance-associated liabilities, and limit drug–drug interactions.<sup><a href="#R14" class="usa-link" aria-describedby="R14">14</a></sup> Doravirine does not interact significantly with known neurotransmitter receptors in vitro<sup><a href="#R14" class="usa-link" aria-describedby="R14">14</a></sup> and has demonstrated a favorable NPAE profile in clinical trials. In a phase 2b trial in treatment-naive participants, the DOR-based regimen demonstrated a superior central nervous system (CNS) safety profile compared with the EFV regimen, with lower rates of treatment-emergent CNS events (26.9% versus 47.2%, respectively) through 24 weeks.<sup><a href="#R18" class="usa-link" aria-describedby="R18">18</a></sup> In the double-blind, 96-week period of the DRIVE-AHEAD trial, participants who initiated the fixed-dose combination of DOR/lamivudine (3TC)/tenofovir disoproxil fumarate (TDF) as first-line therapy had a significantly lower rate of NPAEs (26.4%) than participants who initiated EFV/FTC/TDF (58.5%).<sup><a href="#R19" class="usa-link" aria-describedby="R19">19</a></sup> In the DRIVE-FORWARD trial, participants receiving DOR + 2 NRTIs had similar rates of NPAEs to those receiving ritonavir-boosted darunavir (DRV/r) + 2 NRTIs during the 96 weeks of the double-blind phase.<sup><a href="#R20" class="usa-link" aria-describedby="R20">20</a></sup> In addition, a prospective cohort study demonstrated improvements in NPAEs among persons who switched from InSTI-based treatment to either a DOR- or a cobicistat-boosted darunavir-based regimen, with significant reductions in anxiety, depression, and insomnia 4 and 12 weeks after switch.<sup><a href="#R21" class="usa-link" aria-describedby="R21">21</a></sup></p>
<p>In this study, we report on NPAEs in participants who switched to a DOR-based regimen in the open-label, 96-week extensions of the DRIVE-AHEAD and DRIVE-FORWARD trials, focusing on resolution of NPAEs that had been ongoing from the double-blind phases, and onset and resolution of new NPAEs after switching to a DOR-based regimen in the extension phases.</p></section><section id="s2"><h2 class="pmc_sec_title">METHODS</h2>
<section id="s2-1"><h3 class="pmc_sec_title">Study Design and Population</h3>
<p>The DRIVE-AHEAD (MK-1439A-021, <a href="https://clinicaltrials.gov/ct2/show/NCT02403674" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT02403674</a>) and DRIVE-FORWARD (MK-1439-018, <a href="https://clinicaltrials.gov/ct2/show/NCT02275780" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT02275780</a>) trials were randomized, double-blind, active-controlled, noninferiority trials in adults with previously untreated HIV-1.<sup><a href="#R19" class="usa-link" aria-describedby="R19">19</a>,<a href="#R20" class="usa-link" aria-describedby="R20">20</a>,<a href="#R22" class="usa-link" aria-describedby="R22">22</a>–<a href="#R24" class="usa-link" aria-describedby="R24">24</a></sup> Participants were randomized to a DOR-based regimen (DOR/3TC/TDF or DOR + 2 NRTIs) or a comparator regimen (EFV/FTC/TDF or DRV/r + 2 NRTIs, FTC/TDF or abacavir/3TC) for 96 weeks of double-blind treatment. On completing the double-blind phase, eligible participants in the comparator groups could switch to the study-specific DOR-based regimen for an additional 96 weeks in an open-label study extension (see Figure 1, Supplemental Digital Content, <a href="http://links.lww.com/QAI/C419" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://links.lww.com/QAI/C419</a>). In participants originally randomized to a comparator regimen who switched to a DOR-based regimen in the extensions, we examined the persistence of NPAEs reported during treatment with the comparator in the double-blind phase. We also examined new-onset NPAEs that occurred after participants switched to a DOR-based regimen (see Figure 2, Supplemental Digital Content, <a href="http://links.lww.com/QAI/C419" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://links.lww.com/QAI/C419</a>). All NPAEs were summarized descriptively.</p>
<p>Five categories of NPAEs were predefined: sleep disorders, depression and related disorders (suicide/self-injury), dizziness, altered sensorium, and psychotic disorders. These represent the most commonly reported neuropsychiatric events in the phase 2b study of DOR.<sup><a href="#R18" class="usa-link" aria-describedby="R18">18</a></sup> The specific terms included for each category were based on the MedDRA 23.0. All such events were pooled and evaluated as neuropsychiatric events. The same categories were used to evaluate NPAEs during the double-blind phase of the DRIVE-AHEAD and DRIVE-FORWARD trials.<sup><a href="#R19" class="usa-link" aria-describedby="R19">19</a>,<a href="#R22" class="usa-link" aria-describedby="R22">22</a>,<a href="#R23" class="usa-link" aria-describedby="R23">23</a></sup> Although predefined NPAE categories did not include headache, this was a commonly reported nervous system adverse event in both the DRIVE-AHEAD<sup><a href="#R19" class="usa-link" aria-describedby="R19">19</a>,<a href="#R22" class="usa-link" aria-describedby="R22">22</a></sup> and DRIVE-FORWARD trials,<sup><a href="#R20" class="usa-link" aria-describedby="R20">20</a>,<a href="#R23" class="usa-link" aria-describedby="R23">23</a></sup> and, therefore, was included in this analysis.</p></section></section><section id="s3"><h2 class="pmc_sec_title">RESULTS</h2>
<section id="s3-1"><h3 class="pmc_sec_title">Participant Characteristics</h3>
<p>At the end of the double-blind phase (week 96), 73.9% (269/364) of participants randomized to EFV/FTC/TDF in the DRIVE-AHEAD trial switched to open-label DOR/3TC/TDF and 60.8% (233/383) of participants randomized to DRV/r + 2 NRTIs in the DRIVE-FORWARD trial switched to open-label DOR + 2 NRTIs. Demographics and baseline characteristics of participants who switched to the open-label DOR regimen are shown in Supplemental Digital Content (see Table 1, <a href="http://links.lww.com/QAI/C419" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://links.lww.com/QAI/C419</a>). Across both trials, most participants were assigned male at birth (86.6%) and received TDF in their original regimen (93.6%). In both trials during the double-blind phase, participants who switched to a DOR-based regimen reported similar rates of NPAEs and headache (see Table 1, Supplemental Digital Content, <a href="http://links.lww.com/QAI/C419" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://links.lww.com/QAI/C419</a>) to those reported by all participants originally randomized to the respective comparator groups (see Table 2, Supplemental Digital Content, <a href="http://links.lww.com/QAI/C419" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://links.lww.com/QAI/C419</a>).<sup><a href="#R19" class="usa-link" aria-describedby="R19">19</a>,<a href="#R20" class="usa-link" aria-describedby="R20">20</a></sup> Two participants discontinued the trial extensions because of an NPAE: 1 participant in the DRIVE-AHEAD trial (who switched from EFV/FTC/TDF to DOR/3TC/TDF) because of schizophrenia and 1 participant in the DRIVE-FORWARD trial (who continued with DOR + 2 NRTIs) because of insomnia.</p></section><section id="s3-2"><h3 class="pmc_sec_title">Outcomes for Ongoing NPAEs Reported During the Double-Blind Phase</h3>
<p>In the DRIVE-AHEAD trial, NPAEs were ongoing in 9.7% (26/269) of participants before switch from EFV/FTC/TDF to DOR/3TC/TDF at week 96. After the regimen switch, these NPAEs resolved or were resolving in 73.1% (19/26) of these participants and NPAEs remained ongoing in only 2.6% (7/269) of all participants at week 192. Sleep disorders and disturbances (mainly abnormal dreams and insomnia, see Table 2, Supplemental Digital Content, <a href="http://links.lww.com/QAI/C419" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://links.lww.com/QAI/C419</a>) and dizziness were the most common NPAEs ongoing at week 96 (Fig. <a href="#F1" class="usa-link">1</a>A). At the end of study treatment (week 192 or time of discontinuation), most participants with ongoing sleep disorders and all participants with ongoing dizziness reported resolution of these events after switching to DOR/3TC/TDF (Table <a href="#T1" class="usa-link">1</a>). Headache was ongoing in 5 participants (1.9%) at week 96 and resolved in 3 (1.1%) after the switch. In the DRIVE-FORWARD trial, NPAEs were ongoing in 6.4% of participants (15/233) before switch from DRV/r- to DOR-based regimens at week 96 in the open-label extension. At the end of study treatment, these NPAEs resolved or were resolving, or remained ongoing, in 40.0% (6/15) and 60.0% (9/15) of participants, respectively. Sleep disorders and disturbances (mainly insomnia) and depression were the most common NPAEs ongoing at week 96 (Fig. <a href="#F1" class="usa-link">1</a>B and Table <a href="#T1" class="usa-link">1</a>). Sleep disorders and disturbances resolved in only 1 out of 8 participants after switching to a DOR-based regimen, whereas depression resolved in 5 out of 8 participants (Table <a href="#T1" class="usa-link">1</a>). Headache was ongoing in 4 participants (1.7%) at week 96 and resolved in all 4 after switching to DOR-based regimen.</p>
<figure class="fig xbox font-sm" id="F1"><h4 class="obj_head">FIGURE 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=11970612_qai-99-81-g001.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fe3/11970612/dd45b3108c33/qai-99-81-g001.jpg" loading="lazy" height="454" width="690" alt="FIGURE 1."></a></p>
<div class="p text-right font-secondary"><a href="figure/F1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Persistent NPAEs (A, B) and new-onset NPAEs (C, D) at week 192 in the DRIVE-AHEAD and DRIVE-FORWARD extension phase. A, Persistence of NPAEs at week 192 in DRIVE-AHEAD participants randomized to EFV/FTC/TDF and switched to DOR/3TC/TDF at week 96. B, Persistence of NPAEs at week 192 in DRIVE-FORWARD participants randomized to DRV/r + 2 NRTIs and switched to DOR + 2 NRTIs at week 96. C, Persistence of new-onset NPAEs at week 192 in DRIVE-AHEAD participants randomized to EFV/FTC/TDF and switched to DOR/3TC/TDF at week 96. D, Persistence of new-onset NPAEs at week 192 in DRIVE-FORWARD participants randomized to DRV/r + 2 NRTIs and switched to DOR + 2 NRTIs at week 96.</p></figcaption></figure><section class="tw xbox font-sm" id="T1"><h4 class="obj_head">TABLE 1.</h4>
<div class="caption p"><p>Outcomes for Ongoing NPAEs Reported During the Double-Blind Phase in Participants Who Switched to a DOR-Based Regimen</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead>
<tr>
<td rowspan="3" colspan="1"></td>
<td colspan="2" rowspan="1">DRIVE-AHEAD</td>
<td colspan="2" rowspan="1">DRIVE-FORWARD</td>
</tr>
<tr>
<td colspan="2" rowspan="1">Switch From EFV/FTC/TDF (N = 269)</td>
<td colspan="2" rowspan="1">Switch From DRV/r + 2 NRTIs (N = 233)</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Ongoing at Week 96</td>
<td rowspan="1" colspan="1">Not Resolved by Week 192</td>
<td rowspan="1" colspan="1">Ongoing at Week 96</td>
<td rowspan="1" colspan="1">Not Resolved by Week 192</td>
</tr>
</thead>
<tbody>
<tr>
<td rowspan="1" colspan="1">All NPAEs</td>
<td rowspan="1" colspan="1">26 (9.7)</td>
<td rowspan="1" colspan="1">7 (2.6)</td>
<td rowspan="1" colspan="1">15 (6.4)</td>
<td rowspan="1" colspan="1">9 (3.9)</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Sleep disorders and disturbances</td>
<td rowspan="1" colspan="1">15 (5.6)</td>
<td rowspan="1" colspan="1">5 (1.9)</td>
<td rowspan="1" colspan="1">8 (3.4)</td>
<td rowspan="1" colspan="1">7 (3.0)</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Abnormal dreams</td>
<td rowspan="1" colspan="1">8 (3.0)</td>
<td rowspan="1" colspan="1">3 (1.1)</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">0</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Insomnia</td>
<td rowspan="1" colspan="1">4 (1.5)</td>
<td rowspan="1" colspan="1">1 (0.4)</td>
<td rowspan="1" colspan="1">6 (2.6)</td>
<td rowspan="1" colspan="1">5 (2.1)</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Sleep disorder</td>
<td rowspan="1" colspan="1">2 (0.7)</td>
<td rowspan="1" colspan="1">1 (0.4)</td>
<td rowspan="1" colspan="1">2 (0.9)</td>
<td rowspan="1" colspan="1">2 (0.9)</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Nightmares</td>
<td rowspan="1" colspan="1">1 (0.4)</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">0</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Depression and related disorders</td>
<td rowspan="1" colspan="1">5 (1.9)</td>
<td rowspan="1" colspan="1">3 (1.1)</td>
<td rowspan="1" colspan="1">8 (3.4)</td>
<td rowspan="1" colspan="1">3 (1.3)</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Depression</td>
<td rowspan="1" colspan="1">4 (1.5)</td>
<td rowspan="1" colspan="1">2 (0.7)</td>
<td rowspan="1" colspan="1">5 (2.1)</td>
<td rowspan="1" colspan="1">2 (0.9)</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Depressed mood</td>
<td rowspan="1" colspan="1">1 (0.4)</td>
<td rowspan="1" colspan="1">1 (0.4)</td>
<td rowspan="1" colspan="1">2 (0.9)</td>
<td rowspan="1" colspan="1">1 (0.4)</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Suicidal ideation</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">1 (0.4)</td>
<td rowspan="1" colspan="1">0</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Dizziness</td>
<td rowspan="1" colspan="1">7 (2.6)</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">1 (0.4)</td>
<td rowspan="1" colspan="1">0</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Altered sensorium</td>
<td rowspan="1" colspan="1">2 (0.7)</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">1 (0.4)</td>
<td rowspan="1" colspan="1">1 (0.4)</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Lethargy</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">1 (0.4)</td>
<td rowspan="1" colspan="1">1 (0.4)</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Somnolence</td>
<td rowspan="1" colspan="1">1 (0.4)</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">0</td>
</tr>
<tr>
<td rowspan="1" colspan="1"> Syncope</td>
<td rowspan="1" colspan="1">1 (0.4)</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">0</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Psychotic disorders</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">0</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Headache<a href="#tblfn1" class="usa-link"><sup>*</sup></a>
</td>
<td rowspan="1" colspan="1">5 (1.9)</td>
<td rowspan="1" colspan="1">2 (0.7)</td>
<td rowspan="1" colspan="1">4 (1.7)</td>
<td rowspan="1" colspan="1">0</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="fn1"><p>Specific terms included for each category were based on MedDRA 23.0. A participant with multiple AEs within a category is counted a single time for that category. NRTIs were TDF/FTC or ABC/3TC. The 5 categories of NPAEs were predefined. Data shown as n (%).</p></div>
<div class="fn" id="tblfn1">
<sup>*</sup><p class="display-inline">Headache was not included in the predefined NPAE categories and is not included in the total number of participants with persisting NPAEs.</p>
</div>
</div></section></section><section id="s3-3"><h3 class="pmc_sec_title">New-Onset NPAEs Reported After Switching to a DOR-Based Regimen</h3>
<p>In the DRIVE-AHEAD trial, new-onset NPAEs were reported by 9.3% (25/269) of participants after switching to DOR/3TC/TDF at week 96 (see Table 3, Supplemental Digital Content, <a href="http://links.lww.com/QAI/C419" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://links.lww.com/QAI/C419</a>). Any new-onset NPAEs had resolved or were resolving in 15 participants and remained ongoing in 10 participants (see Table 3, Supplemental Digital Content, <a href="http://links.lww.com/QAI/C419" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://links.lww.com/QAI/C419</a>) by the end of study treatment. One account of drug-related headache was reported, which was considered mild and resolved by the end of study treatment. In the DRIVE-FORWARD trial, any new-onset NPAEs were reported by 7.7% (18/233) of participants after switching to DOR + 2 NRTIs at week 96. New-onset NPAEs had resolved or were resolving in 11 participants and remained ongoing in 7 participants by the end of study treatment (see Table 3, Supplemental Digital Content, <a href="http://links.lww.com/QAI/C419" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://links.lww.com/QAI/C419</a>). In both studies, the most common new-onset NPAEs were sleep disorders and depression (Figs. <a href="#F1" class="usa-link">1</a>C, D). Most new-onset dizziness, altered sensorium, and sleep disorders resolved by the end of the study, while most new-onset depression did not (see Table 3, Supplemental Digital Content, <a href="http://links.lww.com/QAI/C419" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://links.lww.com/QAI/C419</a>). New-onset headache was reported by 5.9% (16/269) and 6.0% (14/233) of participants after switching to DOR/3TC/TDF or DOR + 2 NRTIs, respectively, at week 96 (see Table 3, Supplemental Digital Content, <a href="http://links.lww.com/QAI/C419" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://links.lww.com/QAI/C419</a>). New-onset headache remained ongoing in 1 and 2 participants, respectively, by the end of study treatment.</p></section></section><section id="s4"><h2 class="pmc_sec_title">DISCUSSION AND CONCLUSIONS</h2>
<p>People living with chronic medical conditions, including HIV, are at higher risk of developing a mental health condition than those without chronic medical conditions.<sup><a href="#R25" class="usa-link" aria-describedby="R25">25</a></sup> Neuropsychiatric symptoms, including depression and anxiety, are more prevalent among persons with HIV than those without HIV.<sup><a href="#R26" class="usa-link" aria-describedby="R26">26</a>–<a href="#R31" class="usa-link" aria-describedby="R31">31</a></sup> Antiretrovirals should not precipitate or exacerbate neuropsychiatric symptoms.</p>
<p>Considering that life expectancy among adults with HIV is approaching that of the general population,<sup><a href="#R32" class="usa-link" aria-describedby="R32">32</a></sup> and seeing as HIV therapy must continue indefinitely, the focus of clinical management has evolved to individualizing therapy with the aim of reducing adverse effects, including NPAEs, over the long term. According to current guidelines, persistent or debilitating NPAEs should prompt substitution of EFV to DOR, etravirine, or a boosted protease inhibitor. InSTIs may also be considered for EFV substitution, although monitoring is recommended, particularly in patients with pre-existing psychiatric conditions.<sup><a href="#R9" class="usa-link" aria-describedby="R9">9</a>,<a href="#R33" class="usa-link" aria-describedby="R33">33</a></sup> Discontinuing EFV-based therapy may prompt insomnia or altered sleep patterns until the effects of habitual EFV have resolved,<sup><a href="#R34" class="usa-link" aria-describedby="R34">34</a>,<a href="#R35" class="usa-link" aria-describedby="R35">35</a></sup> and other EFV-associated NPAEs may also resolve slowly after discontinuation.<sup><a href="#R5" class="usa-link" aria-describedby="R5">5</a></sup></p>
<p>We evaluated NPAEs among participants who switched to an open-label DOR-based regimen from double-blind EFV/FTC/TDF in the DRIVE-AHEAD trial or from a double-blind DRV/r-based regimen in the DRIVE-FORWARD trial. In the DRIVE-AHEAD switch group, ∼10% of participants had ongoing NPAEs at the end of EFV treatment (week 96), and most of these participants reported resolution of NPAEs after switching to a DOR-based regimen. In the DRIVE-FORWARD switch group, although 6.0% of participants had ongoing NPAEs at the end of DRV/r treatment, few reported resolution of the NPAEs after switching to a DOR-based regimen, most of which were attributed to unresolved sleep disorders. Sleep disorders are an uncommon side effect of DRV/r (abnormal dreams have been reported in &lt;2% of clinical trial participants)<sup><a href="#R36" class="usa-link" aria-describedby="R36">36</a></sup> and the rate observed here may reflect baseline prevalence of insomnia in the general population,<sup><a href="#R37" class="usa-link" aria-describedby="R37">37</a></sup> and/or be related to disruption of sleep homeostasis owing to as yet unidentified factors related to HIV infection itself.<sup><a href="#R38" class="usa-link" aria-describedby="R38">38</a></sup></p>
<p>In both studies, participants switching to a DOR-based regimen experienced fewer new-onset NPAEs (9.3% after switch from EFV; 7.7% after switch from DRV/r) than participants initially treated with DOR/3TC/TDF in the DRIVE-AHEAD trial (26.4%) or DOR + 2 NRTIs in the DRIVE-FORWARD trial (15.7%).<sup><a href="#R19" class="usa-link" aria-describedby="R19">19</a>,<a href="#R20" class="usa-link" aria-describedby="R20">20</a></sup> Most of the new-onset NPAEs had resolved by the end of the open-label study extension. The most persistent NPAE was depression, a common neuropsychiatric complication in adults with HIV owing to multiple potentially contributing mechanisms,<sup><a href="#R39" class="usa-link" aria-describedby="R39">39</a></sup> which remained ongoing in a total of 10 participants.</p>
<p>Our results are consistent with a previous report from a parallel-group, direct comparison phase 2 trial of DOR-based regimens that demonstrated significantly fewer NPAEs than EFV-based regimens.<sup><a href="#R18" class="usa-link" aria-describedby="R18">18</a></sup> Although in a previous phase 2 study that enrolled participants with CNS complaints while receiving EFV/FTC/TDF and randomized participants to immediate or delayed switch to DOR/3TC/TDF, improvement in NPAEs was not substantially different between the 2 groups<sup><a href="#R40" class="usa-link" aria-describedby="R40">40</a></sup>; selection bias may have skewed the results because only those participants who tolerated EFV well enough to consent to a potential randomization to the deferred switch arm were enrolled, whereas individuals who could not tolerate EFV had likely already discontinued this medication as part of standard clinical care and would not have been enrolled in the trial.<sup><a href="#R40" class="usa-link" aria-describedby="R40">40</a></sup> Furthermore, given that EFV acts as a partial serotonin 5-HT<sub>2A</sub> receptor agonist,<sup><a href="#R5" class="usa-link" aria-describedby="R5">5</a>,<a href="#R15" class="usa-link" aria-describedby="R15">15</a></sup> it is reasonable to expect withdrawal-type syndromes, which may result in an increased frequency of NPAEs after discontinuation of EFV.</p>
<p>The current investigation is likely a more accurate reflection of the difference between EFV and DOR with regard to the incidence, persistence, and resolution of NPAEs, although the study does present limitations. These are post hoc analyses from open-label study extensions without control groups and, although these participants had reported NPAEs at rates similar to those reported by all participants randomized to the respective comparator groups (57.6% versus 58.5% in the DRIVE-AHEAD trial; 17.6% versus 18.8% in the DRIVE-FORWARD trial; see Tables 1 and 2, Supplemental Digital Content, <a href="http://links.lww.com/QAI/C419" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://links.lww.com/QAI/C419</a>) before switching to a DOR-based regimen,<sup><a href="#R19" class="usa-link" aria-describedby="R19">19</a>,<a href="#R20" class="usa-link" aria-describedby="R20">20</a></sup> the participants who entered the extensions may have differed from the original cohort in other ways. In addition, long-term evaluation of NPAEs in participants who did not switch to a DOR-based regimen is not within the scope of this analysis. The incidence of headache during the double-blind phase was also similar for the switch groups and the randomized groups: 16.4% versus 15.4% in the DRIVE-AHEAD trial; 11.2% versus 12.0% in the DRIVE-FORWARD trial (see Tables 1 and 2, Supplemental Digital Content, <a href="http://links.lww.com/QAI/C419" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://links.lww.com/QAI/C419</a>).<sup><a href="#R19" class="usa-link" aria-describedby="R19">19</a>,<a href="#R20" class="usa-link" aria-describedby="R20">20</a></sup> These similarities in NPAEs and headache, before switching to a DOR-based regimen, suggest that the switch groups were not predisposed to report fewer NPAEs after switching to the DOR-based regimen and that the similar rate of headache and NPAEs with DOR- and DRV/r-based regimens may represent the generalized background rate for these events in people living with HIV.<sup><a href="#R26" class="usa-link" aria-describedby="R26">26</a>–<a href="#R30" class="usa-link" aria-describedby="R30">30</a></sup> In addition, although participant medical history was requested at the time of enrollment in the trials, the retrospective nature of those data may have resulted in undercounting of pre-existing neuropsychiatric symptoms, resulting in some symptoms being misclassified as emergent, whereas they may have been present at baseline. Nonetheless, this would have likely affected to a greater extent the analysis from the original double-blind study period rather than the analyses examining the open-label extensions. Finally, these post hoc analyses were insufficiently powered for subgroup analyses because of small sample sizes.</p>
<p>None of the DRIVE-AHEAD and DRIVE-FORWARD trials included a DTG-based regimen as a comparator; therefore, no direct comparison with DTG could be performed based on these trial extensions. However, multiple phase 3 trials evaluating DOR- versus DTG-based regimens for first-line therapy (<a href="https://clinicaltrials.gov/ct2/show/NCT05924438" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT05924438</a> and <a href="https://clinicaltrials.gov/ct2/show/NCT06203132" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT06203132</a>) are underway.</p>
<p>Overall, in both trials, NPAEs persisted in ∼3–4% of participants 96 weeks after switching to a DOR-based regimen. Sleep disorders and depression, which may be caused by factors other than tolerability issues, persisted in ∼1–3% of participants, while all other NPAEs persisted in ∼0–1% of participants. This suggests a DOR-based regimen may represent a good option for adults with HIV and baseline neuropsychiatric symptoms or for those experiencing NPAEs with other antiretroviral regimens.</p></section><section id="sec13"><h2 class="pmc_sec_title">Supplementary Material</h2>
<figure class="fig xbox font-sm" id="s001"><div class="media p"><div class="caption">
<a href="/articles/instance/11970612/bin/qai-99-81-s001.docx" data-ga-action="click_feat_suppl" class="usa-link">qai-99-81-s001.docx</a><sup> (239.3KB, docx) </sup>
</div></div>
<div class="p text-right font-secondary"><a href="figure/s001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></figure></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">ACKNOWLEDGMENTS</h2>
<p>The authors thank all the individuals who participated in the DRIVE-AHEAD and DRIVE-FORWARD studies. The contributions of the investigators (see Table 4, Supplemental Digital Content, <a href="http://links.lww.com/QAI/C419" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://links.lww.com/QAI/C419</a>) and their staff are also gratefully recognized. Medical writing support was provided by Kim M. Strohmaier, MPH, an employee of Merck Sharp &amp; Dohme LLC, a subsidiary of Merck &amp; Co., Inc., Rahway, NJ, USA. Medical writing and/or editorial assistance was provided by Christina Balle and Toinette Labuschagné of ApotheCom (Yardley, PA). This assistance was funded by Merck Sharp &amp; Dohme LLC, a subsidiary of Merck &amp; Co., Inc., Rahway, NJ, USA. Funding for this research was provided by Merck Sharp &amp; Dohme LLC, a subsidiary of Merck &amp; Co., Inc., Rahway, NJ, USA.</p></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm">
<div class="fn p" id="fn3"><p>HIV Glasgow, in Glasgow, UK/Virtual in October 23–26, 2022, and encored at both The British HIV Association (BHIVA) Spring Conference in Gateshead, UK, in April 24–26, 2023, and The Canadian Conference on HIV/AIDS Research (CAHR) in Quebec City, Canada, April 27–30, 2023.</p></div>
<div class="fn p" id="fn4"><p>Funding for this research was provided by Merck Sharp &amp; Dohme LLC, a subsidiary of Merck &amp; Co., Inc., Rahway, NJ, USA.</p></div>
<div class="fn p" id="fn5"><p>F.M., H.W., P.S., R.M.P., and R.L. are current or former employees of Merck Sharp &amp; Dohme LLC, a subsidiary of Merck &amp; Co., Inc., Rahway, NJ, USA, and may own stock and/or options in Merck &amp; Co., Inc., Rahway, NJ, USA. GM has no conflicts to report.</p></div>
<div class="fn p" id="fn6"><p>Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site (<a href="http://www.jaids.com" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">www.jaids.com</a>).</p></div>
<div class="fn p" id="fn7"><p>The data sharing policy, including restrictions, of Merck Sharp &amp; Dohme LLC, a subsidiary of Merck &amp; Co., Inc., Rahway, NJ, USA (MSD), is available at <a href="https://engagezone.msd.com/ds_documentation.php" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://trialstransparency.merckclinicaltrials.com/policies-perspectives.aspx</a>. Requests for access to the clinical study data can be submitted via email to dataaccess@msd.com.</p></div>
<div class="fn p" id="fn8"><p>H.W. and P.S. were employees of Merck Sharp &amp; Dohme LLC, a subsidiary of Merck &amp; Co., Inc., Rahway, NJ, USA, at the time the study was conducted.</p></div>
</div></section><section id="_ci93_" lang="en" class="contrib-info"><h2 class="pmc_sec_title">Contributor Information</h2>
<p>Graeme Moyle, Email: gelyom@gmail.com.</p>
<p>Fanxia Meng, Email: fanxia.meng@merck.com.</p>
<p>Hong Wan, Email: wanhong76@gmail.com.</p>
<p>Peter Sklar, Email: sklarp@gmail.com.</p>
<p>Rebeca M. Plank, Email: rebeca.plank@merck.com.</p></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">REFERENCES</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="R1">
<span class="label">1.</span><cite>d'Arminio Monforte A, Duca PG, Vago L, et al. Decreasing incidence of CNS AIDS-Defining events associated with antiretroviral therapy. Neurology. 2000;54:1856–1859.
</cite> [<a href="https://doi.org/10.1212/wnl.54.9.1856" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10802799/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neurology&amp;title=Decreasing%20incidence%20of%20CNS%20AIDS-Defining%20events%20associated%20with%20antiretroviral%20therapy&amp;author=A%20d'Arminio%20Monforte&amp;author=PG%20Duca&amp;author=L%20Vago&amp;volume=54&amp;publication_year=2000&amp;pages=1856-1859&amp;pmid=10802799&amp;doi=10.1212/wnl.54.9.1856&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R2">
<span class="label">2.</span><cite>Letendre S, Marquie-Beck J, Capparelli E, et al. Validation of the CNS penetration-effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol. 2008;65:65–70.
</cite> [<a href="https://doi.org/10.1001/archneurol.2007.31" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2763187/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18195140/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Arch%20Neurol&amp;title=Validation%20of%20the%20CNS%20penetration-effectiveness%20rank%20for%20quantifying%20antiretroviral%20penetration%20into%20the%20central%20nervous%20system&amp;author=S%20Letendre&amp;author=J%20Marquie-Beck&amp;author=E%20Capparelli&amp;volume=65&amp;publication_year=2008&amp;pages=65-70&amp;pmid=18195140&amp;doi=10.1001/archneurol.2007.31&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R3">
<span class="label">3.</span><cite>Tozzi V, Balestra P, Salvatori MF, et al. Changes in cognition during antiretroviral therapy: comparison of 2 different ranking systems to measure antiretroviral drug efficacy on HIV-Associated neurocognitive disorders. J Acquir Immune Defic Syndr. 2009;52:56–63.
</cite> [<a href="https://doi.org/10.1097/qai.0b013e3181af83d6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19731418/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Acquir%20Immune%20Defic%20Syndr&amp;title=Changes%20in%20cognition%20during%20antiretroviral%20therapy:%20comparison%20of%202%20different%20ranking%20systems%20to%20measure%20antiretroviral%20drug%20efficacy%20on%20HIV-Associated%20neurocognitive%20disorders&amp;author=V%20Tozzi&amp;author=P%20Balestra&amp;author=MF%20Salvatori&amp;volume=52&amp;publication_year=2009&amp;pages=56-63&amp;pmid=19731418&amp;doi=10.1097/qai.0b013e3181af83d6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R4">
<span class="label">4.</span><cite>Abers MS, Shandera WX, Kass JS. Neurological and psychiatric adverse effects of antiretroviral drugs. CNS Drugs. 2014;28:131–145.
</cite> [<a href="https://doi.org/10.1007/s40263-013-0132-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24362768/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=CNS%20Drugs&amp;title=Neurological%20and%20psychiatric%20adverse%20effects%20of%20antiretroviral%20drugs&amp;author=MS%20Abers&amp;author=WX%20Shandera&amp;author=JS%20Kass&amp;volume=28&amp;publication_year=2014&amp;pages=131-145&amp;pmid=24362768&amp;doi=10.1007/s40263-013-0132-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R5">
<span class="label">5.</span><cite>Dalwadi DA, Ozuna L, Harvey BH, et al. Adverse neuropsychiatric events and recreational use of efavirenz and other HIV-1 antiretroviral drugs. Pharmacol Rev. 2018;70:684–711.
</cite> [<a href="https://doi.org/10.1124/pr.117.013706" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29945900/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacol%20Rev&amp;title=Adverse%20neuropsychiatric%20events%20and%20recreational%20use%20of%20efavirenz%20and%20other%20HIV-1%20antiretroviral%20drugs&amp;author=DA%20Dalwadi&amp;author=L%20Ozuna&amp;author=BH%20Harvey&amp;volume=70&amp;publication_year=2018&amp;pages=684-711&amp;pmid=29945900&amp;doi=10.1124/pr.117.013706&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R6">
<span class="label">6.</span><cite>Lanman T, Letendre S, Ma Q, et al. CNS neurotoxicity of antiretrovirals. J Neuroimmune Pharmacol. 2021;16:130–143.
</cite> [<a href="https://doi.org/10.1007/s11481-019-09886-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7282963/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31823251/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Neuroimmune%20Pharmacol&amp;title=CNS%20neurotoxicity%20of%20antiretrovirals&amp;author=T%20Lanman&amp;author=S%20Letendre&amp;author=Q%20Ma&amp;volume=16&amp;publication_year=2021&amp;pages=130-143&amp;pmid=31823251&amp;doi=10.1007/s11481-019-09886-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R7">
<span class="label">7.</span><cite>Hoffmann C, Welz T, Sabranski M, et al. Higher rates of neuropsychiatric adverse events leading to dolutegravir discontinuation in women and older patients. HIV Med. 2017;18:56–63.
</cite> [<a href="https://doi.org/10.1111/hiv.12468" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27860104/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=HIV%20Med&amp;title=Higher%20rates%20of%20neuropsychiatric%20adverse%20events%20leading%20to%20dolutegravir%20discontinuation%20in%20women%20and%20older%20patients&amp;author=C%20Hoffmann&amp;author=T%20Welz&amp;author=M%20Sabranski&amp;volume=18&amp;publication_year=2017&amp;pages=56-63&amp;pmid=27860104&amp;doi=10.1111/hiv.12468&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R8">
<span class="label">8.</span><cite>Hoffmann C, Schewe K, Fenske S, et al. Short-term neuropsychiatric tolerability of bictegravir combined with emtricitabine/tenofovir alafenamide in clinical practice. Antivir Ther. 2020;25:83–90.
</cite> [<a href="https://doi.org/10.3851/IMP3351" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32235038/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Antivir%20Ther&amp;title=Short-term%20neuropsychiatric%20tolerability%20of%20bictegravir%20combined%20with%20emtricitabine/tenofovir%20alafenamide%20in%20clinical%20practice&amp;author=C%20Hoffmann&amp;author=K%20Schewe&amp;author=S%20Fenske&amp;volume=25&amp;publication_year=2020&amp;pages=83-90&amp;pmid=32235038&amp;doi=10.3851/IMP3351&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R9">
<span class="label">9.</span><cite>Kolakowska A, Maresca AF, Collins IJ, et al. Update on adverse effects of HIV integrase inhibitors. Curr Treat Options Infect Dis. 2019;11:372–387.
</cite> [<a href="https://doi.org/10.1007/s40506-019-00203-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7758219/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33380904/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Curr%20Treat%20Options%20Infect%20Dis&amp;title=Update%20on%20adverse%20effects%20of%20HIV%20integrase%20inhibitors&amp;author=A%20Kolakowska&amp;author=AF%20Maresca&amp;author=IJ%20Collins&amp;volume=11&amp;publication_year=2019&amp;pages=372-387&amp;pmid=33380904&amp;doi=10.1007/s40506-019-00203-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R10">
<span class="label">10.</span><cite>Maggiolo F. Efavirenz: a decade of clinical experience in the treatment of HIV. J Antimicrob Chemother. 2009;64:910–928.
</cite> [<a href="https://doi.org/10.1093/jac/dkp334" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2760464/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19767318/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Antimicrob%20Chemother&amp;title=Efavirenz:%20a%20decade%20of%20clinical%20experience%20in%20the%20treatment%20of%20HIV&amp;author=F%20Maggiolo&amp;volume=64&amp;publication_year=2009&amp;pages=910-928&amp;pmid=19767318&amp;doi=10.1093/jac/dkp334&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R11">
<span class="label">11.</span><cite>Kenedi CA, Goforth HW. A systematic review of the psychiatric side-effects of efavirenz. AIDS Behav. 2011;15:1803–1818.
</cite> [<a href="https://doi.org/10.1007/s10461-011-9939-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21484283/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=AIDS%20Behav&amp;title=A%20systematic%20review%20of%20the%20psychiatric%20side-effects%20of%20efavirenz&amp;author=CA%20Kenedi&amp;author=HW%20Goforth&amp;volume=15&amp;publication_year=2011&amp;pages=1803-1818&amp;pmid=21484283&amp;doi=10.1007/s10461-011-9939-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R12">
<span class="label">12.</span><cite>Sustiva. Prescribing information. Bristol Myers Squibb Company, Princeton, NJ, USA; 2019.</cite> [<a href="https://scholar.google.com/scholar_lookup?title=Sustiva.%20Prescribing%20information&amp;publication_year=2019&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R13">
<span class="label">13.</span><cite>Apostolova N, Funes HA, Blas-Garcia A, et al. Efavirenz and the CNS: what we already know and questions that need to be answered. J Antimicrob Chemother. 2015;70:2693–2708.
</cite> [<a href="https://doi.org/10.1093/jac/dkv183" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26203180/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Antimicrob%20Chemother&amp;title=Efavirenz%20and%20the%20CNS:%20what%20we%20already%20know%20and%20questions%20that%20need%20to%20be%20answered&amp;author=N%20Apostolova&amp;author=HA%20Funes&amp;author=A%20Blas-Garcia&amp;volume=70&amp;publication_year=2015&amp;pages=2693-2708&amp;pmid=26203180&amp;doi=10.1093/jac/dkv183&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R14">
<span class="label">14.</span><cite>Hwang C, Lai MT, Hazuda D. Rational design of doravirine: from bench to patients. ACS Infect Dis. 2020;6:64–73.
</cite> [<a href="https://doi.org/10.1021/acsinfecdis.9b00178" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31621289/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ACS%20Infect%20Dis&amp;title=Rational%20design%20of%20doravirine:%20from%20bench%20to%20patients&amp;author=C%20Hwang&amp;author=MT%20Lai&amp;author=D%20Hazuda&amp;volume=6&amp;publication_year=2020&amp;pages=64-73&amp;pmid=31621289&amp;doi=10.1021/acsinfecdis.9b00178&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R15">
<span class="label">15.</span><cite>Gatch MB, Kozlenkov A, Huang RQ, et al. The HIV antiretroviral drug efavirenz has LSD-Like properties. Neuropsychopharmacology. 2013;38:2373–2384.
</cite> [<a href="https://doi.org/10.1038/npp.2013.135" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3799056/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23702798/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuropsychopharmacology&amp;title=The%20HIV%20antiretroviral%20drug%20efavirenz%20has%20LSD-Like%20properties&amp;author=MB%20Gatch&amp;author=A%20Kozlenkov&amp;author=RQ%20Huang&amp;volume=38&amp;publication_year=2013&amp;pages=2373-2384&amp;pmid=23702798&amp;doi=10.1038/npp.2013.135&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R16">
<span class="label">16.</span><cite>Pifeltro. Prescribing information. Merck &amp; Co., Inc., Rahway, NJ, USA; 2024.</cite> [<a href="https://scholar.google.com/scholar_lookup?title=Pifeltro.%20Prescribing%20information&amp;publication_year=2024&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R17">
<span class="label">17.</span><cite>Delstrigo. Prescribing information. Merck &amp; Co., Inc., Rahway, NJ, USA; 2024.</cite> [<a href="https://scholar.google.com/scholar_lookup?title=Delstrigo.%20Prescribing%20information&amp;publication_year=2024&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R18">
<span class="label">18.</span><cite>Gatell JM, Morales-Ramirez JO, Hagins DP, et al. Doravirine dose selection and 96-week safety and efficacy versus efavirenz in antiretroviral therapy-naive adults with HIV-1 infection in a phase IIb trial. Antivir Ther. 2019;24:425–435.
</cite> [<a href="https://doi.org/10.3851/IMP3323" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31355775/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Antivir%20Ther&amp;title=Doravirine%20dose%20selection%20and%2096-week%20safety%20and%20efficacy%20versus%20efavirenz%20in%20antiretroviral%20therapy-naive%20adults%20with%20HIV-1%20infection%20in%20a%20phase%20IIb%20trial&amp;author=JM%20Gatell&amp;author=JO%20Morales-Ramirez&amp;author=DP%20Hagins&amp;volume=24&amp;publication_year=2019&amp;pages=425-435&amp;pmid=31355775&amp;doi=10.3851/IMP3323&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R19">
<span class="label">19.</span><cite>Orkin C, Squires KE, Molina JM, et al. Doravirine/lamivudine/tenofovir disoproxil fumarate (TDF) versus efavirenz/emtricitabine/TDF in treatment-naive adults with human immunodeficiency virus type 1 infection: week 96 results of the randomized, double-blind, phase 3 DRIVE-AHEAD noninferiority trial. Clin Infect Dis. 2021;73:33–42.
</cite> [<a href="https://doi.org/10.1093/cid/ciaa822" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8246893/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33336698/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Infect%20Dis&amp;title=Doravirine/lamivudine/tenofovir%20disoproxil%20fumarate%20(TDF)%20versus%20efavirenz/emtricitabine/TDF%20in%20treatment-naive%20adults%20with%20human%20immunodeficiency%20virus%20type%201%20infection:%20week%2096%20results%20of%20the%20randomized,%20double-blind,%20phase%203%20DRIVE-AHEAD%20noninferiority%20trial&amp;author=C%20Orkin&amp;author=KE%20Squires&amp;author=JM%20Molina&amp;volume=73&amp;publication_year=2021&amp;pages=33-42&amp;pmid=33336698&amp;doi=10.1093/cid/ciaa822&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R20">
<span class="label">20.</span><cite>Molina JM, Squires K, Sax PE, et al. Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 96-week results of a randomised, double-blind, non-inferiority, phase 3 trial. Lancet HIV. 2020;7:e16–e26.
</cite> [<a href="https://doi.org/10.1016/S2352-3018(19)30336-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31740348/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20HIV&amp;title=Doravirine%20versus%20ritonavir-boosted%20darunavir%20in%20antiretroviral-naive%20adults%20with%20HIV-1%20(DRIVE-FORWARD):%2096-week%20results%20of%20a%20randomised,%20double-blind,%20non-inferiority,%20phase%203%20trial&amp;author=JM%20Molina&amp;author=K%20Squires&amp;author=PE%20Sax&amp;volume=7&amp;publication_year=2020&amp;pages=e16-e26&amp;pmid=31740348&amp;doi=10.1016/S2352-3018(19)30336-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R21">
<span class="label">21.</span><cite>Mata-Marin JA, Juarez-Contreras CA, Rodriguez-Evaristo MS, et al. Reversibility of neuropsychiatric adverse events after switching to darunavir/cobicistat or doravirine in men on INSTI-based regimen. Viruses. 2024;16:1083.
</cite> [<a href="https://doi.org/10.3390/v16071083" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11281698/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39066245/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Viruses&amp;title=Reversibility%20of%20neuropsychiatric%20adverse%20events%20after%20switching%20to%20darunavir/cobicistat%20or%20doravirine%20in%20men%20on%20INSTI-based%20regimen&amp;author=JA%20Mata-Marin&amp;author=CA%20Juarez-Contreras&amp;author=MS%20Rodriguez-Evaristo&amp;volume=16&amp;publication_year=2024&amp;pages=1083&amp;pmid=39066245&amp;doi=10.3390/v16071083&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R22">
<span class="label">22.</span><cite>Orkin C Squires KE Molina JM, et al. Doravirine/lamivudine/tenofovir disoproxil fumarate is non-inferior to efavirenz/emtricitabine/tenofovir disoproxil fumarate in treatment-naive adults with human immunodeficiency virus-1 infection: week 48 results of the DRIVE-AHEAD trial. Clin Infect Dis. 2019;68:535–544.
</cite> [<a href="https://doi.org/10.1093/cid/ciy540" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6355823/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30184165/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Infect%20Dis&amp;title=Doravirine/lamivudine/tenofovir%20disoproxil%20fumarate%20is%20non-inferior%20to%20efavirenz/emtricitabine/tenofovir%20disoproxil%20fumarate%20in%20treatment-naive%20adults%20with%20human%20immunodeficiency%20virus-1%20infection:%20week%2048%20results%20of%20the%20DRIVE-AHEAD%20trial&amp;author=C%20Orkin&amp;author=KE%20Squires&amp;author=JM%20Molina&amp;volume=68&amp;publication_year=2019&amp;pages=535-544&amp;pmid=30184165&amp;doi=10.1093/cid/ciy540&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R23">
<span class="label">23.</span><cite>Molina JM, Squires K, Sax PE, et al. Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-inferiority trial. Lancet HIV. 2018;5:e211–e220.
</cite> [<a href="https://doi.org/10.1016/S2352-3018(18)30021-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29592840/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20HIV&amp;title=Doravirine%20versus%20ritonavir-boosted%20darunavir%20in%20antiretroviral-naive%20adults%20with%20HIV-1%20(DRIVE-FORWARD):%2048-week%20results%20of%20a%20randomised,%20double-blind,%20phase%203,%20non-inferiority%20trial&amp;author=JM%20Molina&amp;author=K%20Squires&amp;author=PE%20Sax&amp;volume=5&amp;publication_year=2018&amp;pages=e211-e220&amp;pmid=29592840&amp;doi=10.1016/S2352-3018(18)30021-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R24">
<span class="label">24.</span><cite>Orkin C, Molina JM, Cahn P, et al. Safety and efficacy of doravirine as first-line therapy in adults with HIV-1: week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trials. Lancet HIV. 2024;11:e75–e85.
</cite> [<a href="https://doi.org/10.1016/S2352-3018(23)00258-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38141637/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20HIV&amp;title=Safety%20and%20efficacy%20of%20doravirine%20as%20first-line%20therapy%20in%20adults%20with%20HIV-1:%20week%20192%20results%20from%20the%20open-label%20extensions%20of%20the%20DRIVE-FORWARD%20and%20DRIVE-AHEAD%20phase%203%20trials&amp;author=C%20Orkin&amp;author=JM%20Molina&amp;author=P%20Cahn&amp;volume=11&amp;publication_year=2024&amp;pages=e75-e85&amp;pmid=38141637&amp;doi=10.1016/S2352-3018(23)00258-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R25">
<span class="label">25.</span><cite>US Department of Health and Human Services , National Institutes of Health, National Institute of Mental Health. Chronic illness and mental health—Recognizing and treating
depression; 2021. NIH publication; no. 21-MH-8015.</cite>
</li>
<li id="R26">
<span class="label">26.</span><cite>Lyketsos CG, Hutton H, Fishman M, et al. Psychiatric morbidity on entry to an HIV primary care clinic. AIDS. 1996;10:1033–1039.
</cite> [<a href="https://doi.org/10.1097/00002030-199610090-00015" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8853738/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=AIDS&amp;title=Psychiatric%20morbidity%20on%20entry%20to%20an%20HIV%20primary%20care%20clinic&amp;author=CG%20Lyketsos&amp;author=H%20Hutton&amp;author=M%20Fishman&amp;volume=10&amp;publication_year=1996&amp;pages=1033-1039&amp;pmid=8853738&amp;doi=10.1097/00002030-199610090-00015&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R27">
<span class="label">27.</span><cite>Ciesla JA, Roberts JE. Meta-analysis of the relationship between HIV infection and risk for depressive disorders. Am J Psychiatry. 2001;158:725–730.
</cite> [<a href="https://doi.org/10.1176/appi.ajp.158.5.725" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11329393/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Psychiatry&amp;title=Meta-analysis%20of%20the%20relationship%20between%20HIV%20infection%20and%20risk%20for%20depressive%20disorders&amp;author=JA%20Ciesla&amp;author=JE%20Roberts&amp;volume=158&amp;publication_year=2001&amp;pages=725-730&amp;pmid=11329393&amp;doi=10.1176/appi.ajp.158.5.725&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R28">
<span class="label">28.</span><cite>Do AN, Rosenberg ES, Sullivan PS, et al. Excess burden of depression among HIV-infected persons receiving medical care in the United States: data from the medical monitoring project and the behavioral risk factor surveillance system. PLoS One. 2014;9:e92842.
</cite> [<a href="https://doi.org/10.1371/journal.pone.0092842" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3963963/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24663122/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20One&amp;title=Excess%20burden%20of%20depression%20among%20HIV-infected%20persons%20receiving%20medical%20care%20in%20the%20United%20States:%20data%20from%20the%20medical%20monitoring%20project%20and%20the%20behavioral%20risk%20factor%20surveillance%20system&amp;author=AN%20Do&amp;author=ES%20Rosenberg&amp;author=PS%20Sullivan&amp;volume=9&amp;publication_year=2014&amp;pages=e92842&amp;pmid=24663122&amp;doi=10.1371/journal.pone.0092842&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R29">
<span class="label">29.</span><cite>Lofgren SM, Bond DJ, Nakasujja N, et al. Burden of depression in outpatient HIV-Infected adults in Sub-Saharan Africa; systematic review and meta-analysis. AIDS Behav. 2020;24:1752–1764.
</cite> [<a href="https://doi.org/10.1007/s10461-019-02706-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7478178/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31720956/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=AIDS%20Behav&amp;title=Burden%20of%20depression%20in%20outpatient%20HIV-Infected%20adults%20in%20Sub-Saharan%20Africa;%20systematic%20review%20and%20meta-analysis&amp;author=SM%20Lofgren&amp;author=DJ%20Bond&amp;author=N%20Nakasujja&amp;volume=24&amp;publication_year=2020&amp;pages=1752-1764&amp;pmid=31720956&amp;doi=10.1007/s10461-019-02706-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R30">
<span class="label">30.</span><cite>Desta F, Tasew A, Tekalegn Y, et al. Prevalence of depression and associated factors among people living with HIV/AIDS in public hospitals of Southeast Ethiopia. BMC Psychiatry. 2022;22:557.
</cite> [<a href="https://doi.org/10.1186/s12888-022-04205-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9389682/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35986352/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Psychiatry&amp;title=Prevalence%20of%20depression%20and%20associated%20factors%20among%20people%20living%20with%20HIV/AIDS%20in%20public%20hospitals%20of%20Southeast%20Ethiopia&amp;author=F%20Desta&amp;author=A%20Tasew&amp;author=Y%20Tekalegn&amp;volume=22&amp;publication_year=2022&amp;pages=557&amp;pmid=35986352&amp;doi=10.1186/s12888-022-04205-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R31">
<span class="label">31.</span><cite>Matacotta JJ, Tran D, Yoon S. The prevalence of major depressive disorder in people with HIV: results from the All of Us Research Program. HIV Med. 2024;25:998–1004.
</cite> [<a href="https://doi.org/10.1111/hiv.13653" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38715437/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=HIV%20Med&amp;title=The%20prevalence%20of%20major%20depressive%20disorder%20in%20people%20with%20HIV:%20results%20from%20the%20All%20of%20Us%20Research%20Program&amp;author=JJ%20Matacotta&amp;author=D%20Tran&amp;author=S%20Yoon&amp;volume=25&amp;publication_year=2024&amp;pages=998-1004&amp;pmid=38715437&amp;doi=10.1111/hiv.13653&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R32">
<span class="label">32.</span><cite>Trickey A, Sabin CA, Burkholder G, et al. Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies. Lancet HIV. 2023;10:e295–e307.
</cite> [<a href="https://doi.org/10.1016/S2352-3018(23)00028-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10288029/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36958365/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20HIV&amp;title=Life%20expectancy%20after%202015%20of%20adults%20with%20HIV%20on%20long-term%20antiretroviral%20therapy%20in%20Europe%20and%20North%20America:%20a%20collaborative%20analysis%20of%20cohort%20studies&amp;author=A%20Trickey&amp;author=CA%20Sabin&amp;author=G%20Burkholder&amp;volume=10&amp;publication_year=2023&amp;pages=e295-e307&amp;pmid=36958365&amp;doi=10.1016/S2352-3018(23)00028-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R33">
<span class="label">33.</span><cite>Department of Health and Human Services.
Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. 2019. Updated September 12, 2024. Accessed January 27, 2025. Available at:
<a href="https://clinicalinfo.hiv.gov/en/guidelines/adult-and-adolescent-arv" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://clinicalinfo.hiv.gov/en/guidelines/adult-and-adolescent-arv</a></cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Panel%20on%20Antiretroviral%20Guidelines%20for%20Adults%20and%20Adolescents.%20Guidelines%20for%20the%20use%20of%20antiretroviral%20agents%20in%20adults%20and%20adolescents%20with%20HIV&amp;author=Services.%20Department%20of%20Health%20and%20Human&amp;publication_year=2019&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R34">
<span class="label">34.</span><cite>Moyle G, Fletcher C, Brown H, et al. Changes in sleep quality and brain wave patterns following initiation of an efavirenz-containing triple antiretroviral regimen. HIV Med. 2006;7:243–247.
</cite> [<a href="https://doi.org/10.1111/j.1468-1293.2006.00363.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16630036/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=HIV%20Med&amp;title=Changes%20in%20sleep%20quality%20and%20brain%20wave%20patterns%20following%20initiation%20of%20an%20efavirenz-containing%20triple%20antiretroviral%20regimen&amp;author=G%20Moyle&amp;author=C%20Fletcher&amp;author=H%20Brown&amp;volume=7&amp;publication_year=2006&amp;pages=243-247&amp;pmid=16630036&amp;doi=10.1111/j.1468-1293.2006.00363.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R35">
<span class="label">35.</span><cite>Shikuma CM, Kohorn L, Paul R, et al. Sleep and neuropsychological performance in HIV+ subjects on efavirenz-based therapy and response to switch in therapy. HIV Clin Trials. 2018;19:139–147.
</cite> [<a href="https://doi.org/10.1080/15284336.2018.1511348" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7053430/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30451595/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=HIV%20Clin%20Trials&amp;title=Sleep%20and%20neuropsychological%20performance%20in%20HIV+%20subjects%20on%20efavirenz-based%20therapy%20and%20response%20to%20switch%20in%20therapy&amp;author=CM%20Shikuma&amp;author=L%20Kohorn&amp;author=R%20Paul&amp;volume=19&amp;publication_year=2018&amp;pages=139-147&amp;pmid=30451595&amp;doi=10.1080/15284336.2018.1511348&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R36">
<span class="label">36.</span><cite>Prezista (darunavir). Prescribing information . Janssen Products, Horsham, PA, USA; 2023.</cite> [<a href="https://scholar.google.com/scholar_lookup?Prezista%20(darunavir).%20Prescribing%20information%20.%20Janssen%20Products,%20Horsham,%20PA,%20USA;%202023." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R37">
<span class="label">37.</span><cite>Morin CM, Jarrin DC. Epidemiology of insomnia: prevalence, course, risk factors, and public health burden. Sleep Med Clin. 2022;17:173–191.
</cite> [<a href="https://doi.org/10.1016/j.jsmc.2022.03.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35659072/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sleep%20Med%20Clin&amp;title=Epidemiology%20of%20insomnia:%20prevalence,%20course,%20risk%20factors,%20and%20public%20health%20burden&amp;author=CM%20Morin&amp;author=DC%20Jarrin&amp;volume=17&amp;publication_year=2022&amp;pages=173-191&amp;pmid=35659072&amp;doi=10.1016/j.jsmc.2022.03.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R38">
<span class="label">38.</span><cite>O'Brien KE, Riddell NE, Gomez-Olive FX, et al. Sleep disturbances in HIV infection and their biological basis. Sleep Med Rev. 2022;65:101571.
</cite> [<a href="https://doi.org/10.1016/j.smrv.2021.101571" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35944387/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sleep%20Med%20Rev&amp;title=Sleep%20disturbances%20in%20HIV%20infection%20and%20their%20biological%20basis&amp;author=KE%20O'Brien&amp;author=NE%20Riddell&amp;author=FX%20Gomez-Olive&amp;volume=65&amp;publication_year=2022&amp;pages=101571&amp;pmid=35944387&amp;doi=10.1016/j.smrv.2021.101571&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R39">
<span class="label">39.</span><cite>Nanni MG, Caruso R, Mitchell AJ, et al. Depression in HIV infected patients: a review. Curr Psychiatry Rep. 2015;17:530.
</cite> [<a href="https://doi.org/10.1007/s11920-014-0530-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25413636/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Curr%20Psychiatry%20Rep&amp;title=Depression%20in%20HIV%20infected%20patients:%20a%20review&amp;author=MG%20Nanni&amp;author=R%20Caruso&amp;author=AJ%20Mitchell&amp;volume=17&amp;publication_year=2015&amp;pages=530&amp;pmid=25413636&amp;doi=10.1007/s11920-014-0530-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R40">
<span class="label">40.</span><cite>Nelson M, Winston A, Hill A, et al. Efficacy, safety and central nervous system effects after switch from efavirenz/tenofovir/emtricitabine to doravirine/tenofovir/lamivudine. AIDS. 2021;35:759–767.
</cite> [<a href="https://doi.org/10.1097/QAD.0000000000002804" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33587439/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=AIDS&amp;title=Efficacy,%20safety%20and%20central%20nervous%20system%20effects%20after%20switch%20from%20efavirenz/tenofovir/emtricitabine%20to%20doravirine/tenofovir/lamivudine&amp;author=M%20Nelson&amp;author=A%20Winston&amp;author=A%20Hill&amp;volume=35&amp;publication_year=2021&amp;pages=759-767&amp;pmid=33587439&amp;doi=10.1097/QAD.0000000000002804&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Journal of Acquired Immune Deficiency Syndromes (1999) are provided here courtesy of <strong>Wolters Kluwer Health</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1097/QAI.0000000000003599"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/qai-99-81.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (257.4 KB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/11970612/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/11970612/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC11970612%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC11970612/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC11970612/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC11970612/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/39748155/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC11970612/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/39748155/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC11970612/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/11970612/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="jYoIpNyffEU8SLn9EajWBoed05ARw3sHLCSvPC3ayuJZXx5FMQD0iqCuXZyIZsQG">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Web Policies

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    FOIA

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS Vulnerability Disclosure

    
</a>

                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Help

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Accessibility

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Careers

    
</a>

                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NLM

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NIH

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    USA.gov

    
</a>

                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-370d5dd6.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-917ba005.js"></script>
    
    

    </body>
</html>
